CHICAGO, July 2, 2019 /PRNewswire/ -- According to the new market research report "Hemodialysis & Peritoneal Dialysis Market by Product (Machines, Dialyzers, Concentrates, Dialysates, Catheters) Services, Modality (Conventional, CAPD, Nocturnal), End User (Hospital, Independent Dialysis Center, Home Dialysis) - Global Forecasts to 2024", published by MarketsandMarkets™, the Hemodialysis & Peritoneal Dialysis Market is projected to reach USD 99.2 billion by 2024 from USD 74.2 billion in 2019, at a CAGR of 6.0%.
Download PDF Brochure:
Growth in this market is driven by the increasing number of ESRD patients, growing prevalence of diabetes & hypertension, shortage of organ donors and risks associated with transplant, technological advancements and new product launches, and rising R&D expenditure for developing new dialysis products.
The hemodialysis services segment is expected to account for the largest share of the global hemodialysis market, by type, in 2019
The global hemodialysis market is broadly categorized into two segments, namely, hemodialysis products and hemodialysis services market. The hemodialysis products market include machines (center-use & home-use machines) & consumables (dialyzers, access products, bloodlines, dialysates, and other consumables). The hemodialysis services (including in-center & home- hemodialysis services) segment is expected to account for the largest share of the hemodialysis market. The increasing number of dialysis centers coupled with the growing prevalence of ESRD is the major factor driving the growth of the hemodialysis services market.
Browse in-depth TOC on "Hemodialysis & Peritoneal Dialysis Market"
140 – Tables
54 – Figures
251 – Pages
The automated peritoneal dialysis segment is to register the highest CAGR in the peritoneal dialysis modality market during the forecast period
The peritoneal dialysis market, by modality, includes continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD). The APD segment is expected to grow at the highest CAGR owing to its several advantages over CAPD, such as daytime freedom for patients, fewer connections and disconnections (and hence a lower probability of peritonitis), and improved quality of life. Being automated, APD is also the preferred dialysis treatment for the elderly and children.
"North America to account for the largest share of the global market during the forecast period."
Based on region, the Hemodialysis & Peritoneal Dialysis Market has been segmented into four major regions, namely, North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to account for the largest share of the Hemodialysis & Peritoneal Dialysis Market in 2019. The higher per capita income as compared to other regions, favorable reimbursement scenario, and increasing demand for dialysis procedures are propelling the growth of the market.
Request Research Sample Pages:
The major players operating in the global Hemodialysis & Peritoneal Dialysis Market are Fresenius Medical Care AG & Co. KGaA (Germany), DaVita Healthcare Partners, Inc. (US), Baxter International, Inc. (US), and B. Braun Melsungen AG (Germany). Other players in this market include Ion Nipro Corporation (Japan), Cantel Medical Corporation (US), NIKKISO CO., LTD (Japan), Diaverum Healthcare Partners (Germany), Asahi Kasei Corporation (Japan), Medtronic Plc (Ireland), Rockwell Medical, Inc. (US), Becton, Dickinson and Company (US), Dialife Group (Switzerland), and Isopure Corp. (US), among others.
Browse Adjacent Markets: Medical Devices Market Research Reports & Consulting
Browse Related Reports:
Asia and North Africa Hemodialysis & Peritoneal Dialysis Market by Products (Machine, Dialyzer, Bloodlines, Concentrates, Catheters, & Transfer Sets) and Services (In-Center and Home) - Forecast to 2020
Continuous Renal Replacement Therapy Market by Adoption & Procedures, Product (Disposables (Hemofilters & Bloodlines), Systems, & Dialysate), Modality (SCUF, CVVH, CVVHD, CVVHDF), and Region (North America, Asia-Pacific, Europe) - Global Forecast to 2022
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Shelly Singh
630 Dundee Road
Northbrook, IL 60062
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/dialysis-market.asp
Visit Our Website: https://www.marketsandmarkets.com
Content Source: https://www.marketsandmarkets.com/PressReleases/dialysis.asp